Product Images Cisatracurium Besylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Cisatracurium Besylate NDC 55150-284 by Eugia Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Maximum Percent Change from Preinjection in HR and MAP During First 5 Minutes after Initial 4 × ED95 to 8 × ED95 Cisatracurium Doses in Healthy Adults Who Received Opioid/Nitrous Oxide/Oxygen Anesthesia (n = 44) - cisatracurium fig1
Figure 2. Percent Change from Preinjection in HR and MAP 10 Minutes After an Initial 4 × ED95 to 8 × ED95 Cisatracurium Dose in Patients Undergoing CABG Surgery Receiving Oxygen/Fentanyl/Midazolam/Anesthesia (n = 54) - cisatracurium fig2
The text seems to be showing percentages (+60% and -60%) along with the abbreviation HR. It is not clear what the percentages are referring to, so it is difficult to provide a specific description.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg (base) / 5 mL (2 mg / mL) - Container Label - cisatracurium fig3
This is a product label for a medication called Cisatracurium Besylate from the company Auromedics. It comes in a single-dose vial containing 10 mg of the medication in 5mL of solution. It is a paralyzing agent intended for intravenous injection and facilities must have artficial respiration available in case of respiratory arrest. It needs to be stored at a temperature between 2° to 8°C to prevent freezing and protected from light. The medication needs to be used within 21 days of being removed from refrigeration, even if it has been previously refrigerated. It does not contain preservatives. The discard code is TS/DRUGS/13/2010 and it is manufactured in Windsor, NJ 08520.*
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 10 mg per 5 mL (2 mg per mL) - Container-Carton (10 Vials) - cisatracurium fig4
This is a medication description for Cisatracurium Besylate Injection, used for intravenous injection as a paralyzing agent. It contains 10mg per 5mL of Cisatracurium. The medication should be stored between 2°C and 5°C, and unused portions of the single-dose vials should be discarded. The warning is given that the medication may cause respiratory arrest and should be used under medical supervision. Additionally, the vial stoppers are not made with natural rubber latex.*
cisatracurium-figure 5 - cisatracurium fig5
This appears to be a label or instructions for Cisatracurium Besylate Injection, a medication that is available in milligrams per milliliter strength. The text also instructs to peel off something and apply it to a syringe, although it is unclear what this refers to without additional context. Finally, there are some codes or identifying information listed: "Dt" may refer to a date, "Tm" to a time, "By" to a person or company responsible for the product, and "P1416958" to a product or batch number. Overall, this text may be of limited usefulness without additional information.*
Chemical Structure - cisatracurium str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.